These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 25668435)

  • 1. Oxytocin increases eye contact during a real-time, naturalistic social interaction in males with and without autism.
    Auyeung B; Lombardo MV; Heinrichs M; Chakrabarti B; Sule A; Deakin JB; Bethlehem RA; Dickens L; Mooney N; Sipple JA; Thiemann P; Baron-Cohen S
    Transl Psychiatry; 2015 Feb; 5(2):e507. PubMed ID: 25668435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and neural effects of six-week administration of oxytocin on core symptoms of autism.
    Watanabe T; Kuroda M; Kuwabara H; Aoki Y; Iwashiro N; Tatsunobu N; Takao H; Nippashi Y; Kawakubo Y; Kunimatsu A; Kasai K; Yamasue H
    Brain; 2015 Nov; 138(Pt 11):3400-12. PubMed ID: 26336909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxytocin biases eye-gaze to dynamic and static social images and the eyes of fearful faces: associations with trait autism.
    Le J; Kou J; Zhao W; Fu M; Zhang Y; Becker B; Kendrick KM
    Transl Psychiatry; 2020 May; 10(1):142. PubMed ID: 32398642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative facial expression analysis revealed the efficacy and time course of oxytocin in autism.
    Owada K; Okada T; Munesue T; Kuroda M; Fujioka T; Uno Y; Matsumoto K; Kuwabara H; Mori D; Okamoto Y; Yoshimura Y; Kawakubo Y; Arioka Y; Kojima M; Yuhi T; Yassin W; Kushima I; Benner S; Ogawa N; Kawano N; Eriguchi Y; Uemura Y; Yamamoto M; Kano Y; Kasai K; Higashida H; Ozaki N; Kosaka H; Yamasue H
    Brain; 2019 Jul; 142(7):2127-2136. PubMed ID: 31096266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxytocin-induced increase in N,N-dimethylglycine and time course of changes in oxytocin efficacy for autism social core symptoms.
    Kato Y; Kuwabara H; Okada T; Munesue T; Benner S; Kuroda M; Kojima M; Yassin W; Eriguchi Y; Kameno Y; Murayama C; Nishimura T; Tsuchiya K; Kasai K; Ozaki N; Kosaka H; Yamasue H
    Mol Autism; 2021 Feb; 12(1):15. PubMed ID: 33622389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of multiple-dose intranasal oxytocin administration on social responsiveness in children with autism: a randomized, placebo-controlled trial.
    Daniels N; Moerkerke M; Steyaert J; Bamps A; Debbaut E; Prinsen J; Tang T; Van der Donck S; Boets B; Alaerts K
    Mol Autism; 2023 Apr; 14(1):16. PubMed ID: 37081454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of oxytocin nasal spray on social interaction deficits observed in young children with autism: a randomized clinical crossover trial.
    Yatawara CJ; Einfeld SL; Hickie IB; Davenport TA; Guastella AJ
    Mol Psychiatry; 2016 Sep; 21(9):1225-31. PubMed ID: 26503762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxytocin increases retention of social cognition in autism.
    Hollander E; Bartz J; Chaplin W; Phillips A; Sumner J; Soorya L; Anagnostou E; Wasserman S
    Biol Psychiatry; 2007 Feb; 61(4):498-503. PubMed ID: 16904652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders.
    Guastella AJ; Einfeld SL; Gray KM; Rinehart NJ; Tonge BJ; Lambert TJ; Hickie IB
    Biol Psychiatry; 2010 Apr; 67(7):692-4. PubMed ID: 19897177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxytocin efficacy is modulated by dosage and oxytocin receptor genotype in young adults with high-functioning autism: a 24-week randomized clinical trial.
    Kosaka H; Okamoto Y; Munesue T; Yamasue H; Inohara K; Fujioka T; Anme T; Orisaka M; Ishitobi M; Jung M; Fujisawa TX; Tanaka S; Arai S; Asano M; Saito DN; Sadato N; Tomoda A; Omori M; Sato M; Okazawa H; Higashida H; Wada Y
    Transl Psychiatry; 2016 Aug; 6(8):e872. PubMed ID: 27552585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasal oxytocin for social deficits in childhood autism: a randomized controlled trial.
    Dadds MR; MacDonald E; Cauchi A; Williams K; Levy F; Brennan J
    J Autism Dev Disord; 2014 Mar; 44(3):521-31. PubMed ID: 23888359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral effects of multiple-dose oxytocin treatment in autism: a randomized, placebo-controlled trial with long-term follow-up.
    Bernaerts S; Boets B; Bosmans G; Steyaert J; Alaerts K
    Mol Autism; 2020; 11(1):6. PubMed ID: 31969977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infrequent Intranasal Oxytocin Followed by Positive Social Interaction Improves Symptoms in Autistic Children: A Pilot Randomized Clinical Trial.
    Le J; Zhang L; Zhao W; Zhu S; Lan C; Kou J; Zhang Q; Zhang Y; Li Q; Chen Z; Fu M; Montag C; Zhang R; Yang W; Becker B; Kendrick KM
    Psychother Psychosom; 2022; 91(5):335-347. PubMed ID: 35545057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of oxytocin administration on salivary sex hormone levels in autistic and neurotypical women.
    Procyshyn TL; Lombardo MV; Lai MC; Auyeung B; Crockford SK; Deakin J; Soubramanian S; Sule A; Baron-Cohen S; Bethlehem RAI
    Mol Autism; 2020 Mar; 11(1):20. PubMed ID: 32188502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visual systemizing preference in children with autism: A randomized controlled trial of intranasal oxytocin.
    Strathearn L; Kim S; Bastian DA; Jung J; Iyengar U; Martinez S; Goin-Kochel RP; Fonagy P
    Dev Psychopathol; 2018 May; 30(2):511-521. PubMed ID: 28712371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders.
    Hollander E; Novotny S; Hanratty M; Yaffe R; DeCaria CM; Aronowitz BR; Mosovich S
    Neuropsychopharmacology; 2003 Jan; 28(1):193-8. PubMed ID: 12496956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute oxytocin improves memory and gaze following in male but not female nursery-reared infant macaques.
    Simpson EA; Paukner A; Sclafani V; Kaburu SS; Suomi SJ; Ferrari PF
    Psychopharmacology (Berl); 2017 Feb; 234(3):497-506. PubMed ID: 27837331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intranasal oxytocin on the core social symptoms of autism spectrum disorder: a randomized clinical trial.
    Yamasue H; Okada T; Munesue T; Kuroda M; Fujioka T; Uno Y; Matsumoto K; Kuwabara H; Mori D; Okamoto Y; Yoshimura Y; Kawakubo Y; Arioka Y; Kojima M; Yuhi T; Owada K; Yassin W; Kushima I; Benner S; Ogawa N; Eriguchi Y; Kawano N; Uemura Y; Yamamoto M; Kano Y; Kasai K; Higashida H; Ozaki N; Kosaka H
    Mol Psychiatry; 2020 Aug; 25(8):1849-1858. PubMed ID: 29955161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoting social behavior with oxytocin in high-functioning autism spectrum disorders.
    Andari E; Duhamel JR; Zalla T; Herbrecht E; Leboyer M; Sirigu A
    Proc Natl Acad Sci U S A; 2010 Mar; 107(9):4389-94. PubMed ID: 20160081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a novel nasal oxytocin spray with enhanced bioavailability on autism: a randomized trial.
    Yamasue H; Kojima M; Kuwabara H; Kuroda M; Matsumoto K; Kanai C; Inada N; Owada K; Ochi K; Ono N; Benner S; Wakuda T; Kameno Y; Inoue J; Harada T; Tsuchiya K; Umemura K; Yamauchi A; Ogawa N; Kushima I; Ozaki N; Suyama S; Saito T; Uemura Y; Hamada J; Kano Y; Honda N; Kikuchi S; Seto M; Tomita H; Miyoshi N; Matsumoto M; Kawaguchi Y; Kanai K; Ikeda M; Nakamura I; Isomura S; Hirano Y; Onitsuka T; Kosaka H; Okada T
    Brain; 2022 Apr; 145(2):490-499. PubMed ID: 35067719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.